| ID | Name | CAS | Data |
logPoct/wat |
| 12-553-4 |
1H-Pyrrolizine-7-methanol, 2,3,5,7a-tetrahydro-1-hydroxy-, (1S-cis)-
|
520-63-8 |
3 | -0.646 |
| 12-567-9 |
trans-1-Methyl-2-tert-butyl-3-(tert-butylimino)diaziridine
|
23044-57-7 |
3 | 2.102 |
| 12-883-8 |
L-Proline, N-trifluoroacetyl-, 2,2,3,3,3-pentafluoropropyl ester
|
|
3 | 2.280 |
| 13-084-4 |
[1R-(1«alpha»,7a«beta»)]-[1-((Z)-2-Methyl-1-oxobut-2-enyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl ester of (Z)-2-hydroxymethylbut-2-enoic acid
|
87340-27-0 |
3 | 1.361 |
| 13-391-3 |
2H-Furo[2,3-h]-1-benzopyran-2-one, 8,9-dihydro-8-(1-hydroxy-1-methylethyl)-, (S)-
|
3804-70-4 |
3 | 1.867 |
| 13-413-8 |
3,5-Dihydro-4-(methylimino)-4H-pyrazole, 3,3,5,5-tetramethyl-
|
72443-11-9 |
3 | 2.080 |
| 13-921-4 |
1,3-Hexadiene, adduct with 4-methyl-1,2,4-triazolin-3,5-dione
|
|
3 | -0.131 |
| 14-839-5 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5,6-trimethyl-7,7-tetramethylene
|
|
3 | 1.026 |
| 15-320-9 |
1H-Pyrrolizine-1-methanol, hexahydro-7-hydroxy-, [1S-(1«alpha»,7«alpha»,7a«beta»)]-
|
520-62-7 |
3 | -0.566 |
| 15-806-0 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 1-methyl-2-isopropenyl hydrazide
|
|
3 | 0.346 |
| 16-407-2 |
Benzofuran-2,3-dione, 2-[O-(2-acetoxyethyl)oxime], 3-(O-methyloxime), isomer 2
|
|
3 | 1.323 |
| 16-587-3 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 5,6-trimethyleno, 6-methyl
|
|
3 | 1.492 |
| 16-837-5 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-phenyl-
|
2097-19-0 |
3 | 0.212 |
| 17-121-8 |
6,7,8,9,10,11-Hexahydro-4a,12-diaza-cycloocta[b]naphthalen-5-one
|
|
3 | 2.353 |
| 17-174-0 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
20431-93-0 |
3 | 2.186 |
| 17-274-9 |
6H-Pyrazolo[1,2-a][1,2,4,5]tetrazine, hexahydro-2,3-dimethyl-
|
70517-50-9 |
3 | -0.384 |
| 18-152-3 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 3-methyl
|
|
3 | 1.003 |
| 18-998-5 |
3H-Pyrazol-3-one, 2,4-dihydro-2,5-dimethyl-
|
2749-59-9 |
3 | 0.224 |
| 19-532-0 |
N,n-dimethyl-p-methyl phosphonamidic acid, n-propyl ester
|
|
3 | 1.797 |
| 20-274-5 |
[(1R)-7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] hexanoate
|
|
3 | 1.733 |
| 20-740-7 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5-dimethyl-7,7-tetramethylene
|
|
3 | 0.684 |
| 21-019-7 |
Thiazolo[3,2-a]pyridinium, 3-hydroxy-2-phenyl-, hydroxide, inner salt
|
|
3 | 2.227 |
| 21-246-5 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5,6-trimethyl
|
|
3 | -0.287 |
| 22-150-0 |
5,5-Dimethyl-2-phenyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1.963 |
| 22-200-4 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine-4,13(14H)-dione, decahydro-, [7S-(7«alpha»,7a«beta»,14«alpha»,14a«alpha»)]-
|
|
3 | 1.398 |
| 22-377-9 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro-6-methyl
|
|
3 | 1.882 |
| 22-392-2 |
Cyclopentyl-hydroxy-phenyl-acetic acid 1-methyl-pyrrolidin-3-yl ester
|
|
3 | 2.312 |
| 22-415-6 |
Thiazolo[3,2-a]pyridinium, 8-hydroxy-3-methyl-, hydroxide, inner salt
|
30276-99-4 |
3 | 0.869 |
| 22-588-5 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 2,2-tetramethylene hydrazide
|
|
3 | -0.023 |
| 22-957-5 |
4H-cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro
|
|
3 | 1.183 |
| 23-018-6 |
Thiazolo[3,2-a]pyridinium, 2,3-dihydro-8-hydroxy-5-methyl-, hydroxide, inner salt
|
23003-43-2 |
3 | 0.462 |
| 23-171-6 |
2,5,5-Trimethyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 0.935 |
| 23-277-9 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«beta»,4a«alpha»,8a«beta»)
|
38463-55-7 |
3 | 2.024 |
| 24-071-6 |
Imidazole, 2,3-dihydro-1-methyl-2-acetylimino-3-acetyl-4acetyloxy-
|
|
3 | -0.141 |
| 24-886-2 |
4-CHLORO-3-(3-METHYL-5-OXO-2-PYRAZOLIN-1-YL)BENZENESULFONIC ACID
|
|
3 | 1.699 |
| 25-019-3 |
2,3,5,6,7,8-Hexahydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
88491-50-3 |
3 | 1.068 |
| 25-282-1 |
[(7R)-7-Hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl hexanoate
|
|
3 | 1.485 |
| 25-902-2 |
1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, decahydro-
|
18161-94-9 |
3 | 0.607 |
| 26-538-6 |
Thiazolo[3,2-a]pyridinium, 8-hydroxy-3,5-dimethyl-, hydroxide, inner salt
|
|
3 | 1.177 |
| 26-810-3 |
3,3,7,7-Tetramethyl-1,5-diazabicyclo[3.3.0]octane
|
2940-98-9 |
3 | 1.585 |
| 27-489-0 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-4-one, 1,2,3,7,9,10,11,13,14,14a-decahydro-, [7S-(7«alpha»,14«alpha»,14a«alpha»)]-
|
35611-60-0 |
3 | 1.997 |
| 27-524-0 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
20422-70-2 |
3 | 2.410 |
| 27-834-6 |
Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1S-[1«alpha»,7(2R*,3R*),7a«alpha»]]-
|
480-83-1 |
3 | -0.327 |
| 27-941-7 |
Furan-3-carboxylic acid, 4-methyl-2-(2-methoxycarbonylethyl)-5-(4-hydroxypentyl), methyl ester
|
|
3 | 2.184 |
| 28-396-2 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl-7,7-pentamethylene
|
|
3 | 1.074 |
| 28-866-0 |
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-1,3,7-trimethyl-
|
|
3 | -2.218 |
| 29-281-8 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro-6-methyl-
|
|
3 | 1.141 |
| 29-375-4 |
4-Quinolinol, 4-ethynyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
14788-65-9 |
3 | 1.634 |
| 29-453-7 |
[(3R)-7-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (E)-3-methylpent-2-enoate
|
|
3 | 1.482 |
| 29-716-5 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«beta»,8a«alpha»)
|
38463-56-8 |
3 | 2.024 |
| 29-986-6 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
20431-95-2 |
3 | 2.186 |
| 30-026-9 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
20422-72-4 |
3 | 2.410 |
| 30-247-4 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 9-methyl
|
|
3 | 1.003 |
| 30-619-1 |
2-Amino-4,6-dihydroxypyrimidine, N,O,O'-tris(trifluoroacetyl)-
|
|
3 | 1.913 |
| 31-195-1 |
Thiazolo[3,2-a]pyridinium,3,8-dihydroxy-,hydroxide,inner salt
|
35143-55-6 |
3 | 0.266 |
| 32-570-3 |
Phosphorothioic acid, S-[2-[(1-cyano-1-methylethyl)amino]-2-oxoethyl] O,O-diethyl ester
|
3734-95-0 |
3 | 2.319 |
| 32-772-9 |
7H-imidazo[4,5-d]-v-triazin-4-ol, 7-butyl-, (keto form)
|
|
3 | -0.167 |
| 32-817-9 |
5,5-Diethyl-2-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1.715 |
| 33-526-1 |
1-[[(1S)-2,3,4,6,7,8,9,9a-Octahydro-1H-quinolizin-1-yl]methyl]pyrrolidine-2,5-dione
|
|
3 | 1.400 |
| 34-074-2 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 3-methyl
|
|
3 | 0.888 |
| 34-609-8 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 7-methyl
|
|
3 | 1.003 |
| 36-920-0 |
2,5,5-Trimethyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 1.325 |
| 37-178-4 |
1,3-Dimethyl-5-(3-hydroxycyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
3 | 0.124 |
| 37-522-1 |
trans-(±)-5-hydroxy-«alpha»,«alpha»,4-trimethylcyclohex-3-ene-1-methanol
|
32226-54-3 |
3 | 2.351 |
| 38-174-7 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl-7,7-tetramethylene
|
|
3 | 0.684 |
| 38-787-7 |
1H,5H,7H,11H-Dipyrazolo[1,2-a:1',2'-d][1,2,4,5]tetrazine, tetrahydro-
|
37882-92-1 |
3 | -0.240 |
| 39-739-9 |
2-Methyl-5-(fur-3-yl)-pent-1-en-3-ol
|
|
3 | 2.149 |
| 40-056-5 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro- 9-methyl
|
|
3 | 1.819 |
| 40-865-7 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7,7-tetramethylene
|
|
3 | 1.151 |
| 41-507-3 |
2-(2,6-Dioxo-3-piperidyl)isoindoline-1,3-dione, N-trimethylsilyl-
|
|
3 | 1.635 |
| 41-554-1 |
1-Methyl-9-[(1e)-1-propenyl]-1,9-dihydro-6h-purin-6-one
|
|
3 | 0.621 |
| 42-134-6 |
1,2,3,4,6,7,8,9,10,11-Decahydro-5,11a-diaza-cycloocta[b]naphthalen-12-one
|
|
3 | 2.239 |
| 43-109-3 |
2,3-Diazabicyclo[2.2.2]octane,1,2,3,4-tetramethyl-,trans-
|
|
3 | 1.870 |
| 43-278-6 |
6-methyl-1,2,3,4,5,6-hexahydro-(7H)-cyclopentapyridine-7-one
|
|
3 | 1.407 |
| 43-471-1 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 2,9-dimethyl
|
|
3 | 1.311 |
| 43-815-9 |
4-Quinolinol, 4-ethynyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
16067-80-4 |
3 | 1.634 |
| 43-838-4 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 7-methyl
|
|
3 | 0.826 |
| 43-987-9 |
N-(5-Methylisoxazol-3-yl)-N-(trifluoroacetyl)-2,2,2-trifluoroacetamide
|
|
3 | 1.967 |
| 44-200-0 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N6-acetyl
|
|
3 | -0.014 |
| 44-752-8 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7,7-pentamethylene
|
|
3 | 1.541 |
| 45-460-1 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 1.004 |
| 45-501-5 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-metyl-phosphorothioamidate
|
|
3 | 2.081 |
| 46-049-7 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro
|
|
3 | 1.733 |
| 46-472-7 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«beta»,8a«alpha»)-
|
20431-91-8 |
3 | 2.186 |
| 46-541-0 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl
|
|
3 | -0.629 |
| 46-758-0 |
Glutarimide, 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, semicarbazone
|
3428-71-5 |
3 | 0.497 |
| 47-116-1 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,6,7,7-tetramethyl
|
|
3 | 0.474 |
| 47-270-0 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N2,N4,N6-tris(trifluoroacetate)
|
|
3 | 1.931 |
| 47-524-8 |
2-Butenoic acid, 2-methyl-, 2,3,5,7a-tetrahydro-7-(hydroxymethyl)-1H-pyrrolizin-1-yl ester, [1S-[1«alpha»(Z),7a«alpha»]]-
|
723-78-4 |
3 | 0.871 |
| 48-631-8 |
2H-1,3,4-Thiadiazine, tetrahydro-2,2,4,6-tetramethyl-
|
|
3 | 1.294 |
| 48-877-6 |
1,2,3,4,6,7,8,9-Octahydro-pyrido[2,1-b]quinazolin-11-one
|
|
3 | 1.458 |
| 48-923-4 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 2-isopropenyl hydrazide
|
|
3 | 0.362 |
| 48-988-3 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-methyl-phosphorothioamidate
|
|
3 | 1.925 |
| 49-434-6 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 9-methyl
|
|
3 | 1.141 |
| 50-303-9 |
1,3-Dimethyl-5-(3-oxocyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
3 | 0.332 |
| 51-118-4 |
3,7-Diazabicyclo[3.3.1]nonane, 3,7-dimethyl-
|
14789-33-4 |
3 | 0.500 |
| 51-266-0 |
1-Methyl-2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
3 | 1.904 |
| 51-638-7 |
Thiazolo[3,2-a]pyridinium, 2,3-dihydro-8-hydroxy-, hydroxide, inner salt
|
23003-45-4 |
3 | 0.153 |
| 52-092-2 |
2-Ethyl-5,5-dimethyl-5-propionyl-1,3,4-oxadiazoline
|
|
3 | 1.715 |
| 52-132-7 |
Propanoic acid, 3-[N-(2-formyl-5-methyl-1-pyrrolyl)]
|
|
3 | 1.084 |
|
« Previous Results
Next Results »
|